+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Experimental Cynomolgus Monkey Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6090247
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Experimental Cynomolgus Monkey Market is projected to reach USD 357.72 Million in 2026. It is expected to continue growing at a CAGR of 6.81%, reaching USD 533.30 Million by 2032.

Experimental Cynomolgus Monkeys: Executive Overview

Experimental cynomolgus monkeys are used in biomedical research because their physiology, immune responses, and disease pathways can support translational studies relevant to human health. Applications commonly include safety assessment, infectious-disease research, neuroscience, immunology, and evaluation of biologic therapies. The field is shaped by scientific validity, animal-welfare expectations, regulatory oversight, supply-chain integrity, and the development of alternatives to animal use.

How Regulation, Welfare, and Translational Science Are Reshaping Research

The landscape is shifting toward higher standards for ethical review, documented animal sourcing, veterinary care, enrichment, humane endpoints, and transparent reporting. Researchers are also placing greater emphasis on study design, statistical rigor, preregistration where appropriate, and reproducibility. These changes favor institutions that can demonstrate necessity, minimize animal use, improve welfare, and connect nonclinical findings to clinically relevant endpoints.

Artificial Intelligence Strengthens Study Design and Animal-Use Decisions

Artificial intelligence can support experimental cynomolgus monkey research by improving protocol design, identifying patterns in longitudinal observations, prioritizing candidate compounds, and integrating imaging, laboratory, and clinical datasets. Computer vision may assist welfare monitoring and detection of behavioral or physiological changes, while machine-learning models can help identify studies that require refinement. AI does not replace ethical review, veterinary judgment, or validation; its value depends on representative data, explainability, secure governance, and prospective performance assessment.

Regional Insights Across Research, Regulation, and Supply Networks

North America combines advanced biomedical infrastructure with intensive oversight of animal research and growing investment in replacement, reduction, and refinement methods. Europe places strong emphasis on harmonized welfare principles, authorization procedures, and alternative methodologies. Asia-Pacific remains important for biomedical research capacity and specialized breeding and laboratory networks, with regulatory practices varying by jurisdiction. Latin America is developing research capabilities while managing access, ethics, and import or export requirements. The Middle East is expanding life-science infrastructure in selected hubs and must align institutional growth with robust welfare governance. Africa’s activity is more uneven, making local capacity building, veterinary expertise, and ethically governed collaboration especially important.

Group Insights: Multilateral Alignment and Divergent Operating Conditions

ASEAN countries are developing biomedical capabilities at different speeds, creating opportunities for shared standards, training, and regional logistics coordination. BRICS members span major research systems with varied rules for sourcing, oversight, and data exchange, so cross-border projects require careful legal and ethical alignment. The European Union emphasizes common welfare principles and formal authorization processes. G7 members generally have mature research governance and strong expectations for reproducibility and alternatives. GCC states are investing in life-science infrastructure while building specialized oversight capacity. NATO members do not operate under one animal-research framework, but defense-related biomedical work can increase the importance of secure data handling, biosafety, and harmonized ethical review.

Country Insights: Distinct Regulatory and Research Priorities

Australia, Canada, France, Germany, Italy, Spain, the United Kingdom, the United States, and Japan maintain substantial biomedical research ecosystems with formal animal-care requirements and increasing attention to alternatives. China and India have broadening life-science capabilities, with institutional standards and enforcement practices continuing to evolve across sectors and regions. South Korea combines advanced biotechnology with structured laboratory-animal oversight. Brazil and Mexico are important Latin American research centers where capacity, sourcing controls, and regulatory coordination remain central considerations. Russia retains scientific infrastructure but may face collaboration, procurement, and data-access constraints that affect international studies. Across all countries, institutions must verify provenance, permits, quarantine procedures, welfare controls, and the scientific necessity of primate use.

Actions for Leaders: Build Ethical, Reproducible, and Resilient Programs

Industry and research leaders should establish a documented hierarchy that prioritizes validated non-animal methods before primate studies, and they should require a clear scientific justification when animal use remains necessary. Strengthen supplier due diligence through provenance records, health screening, chain-of-custody documentation, and contingency planning. Standardize welfare indicators, humane endpoints, enrichment practices, and independent veterinary review across sites. Invest in interoperable data systems and carefully validated AI tools for monitoring and analysis. Finally, use preregistered protocols, blinded assessments where feasible, harmonized outcome measures, and transparent reporting to improve reproducibility and regulatory confidence.

Methodology: Evidence-Led Review of the Experimental Primate Ecosystem

This executive summary is based on a structured assessment of the experimental cynomolgus monkey ecosystem, focusing on established research applications, scientific and ethical drivers, regulatory considerations, regional operating conditions, and technology-enabled changes. Insights should be validated against current legislation, institutional policies, peer-reviewed literature, public animal-welfare guidance, and documented sourcing and health-screening requirements. Because rules and operating conditions differ by jurisdiction, country-level conclusions should be interpreted as directional context rather than a substitute for local legal or ethical review.

Conclusion: Scientific Utility Must Advance With Responsible Stewardship

Experimental cynomolgus monkeys remain relevant to selected translational research questions, but their use is increasingly judged by necessity, rigor, welfare, and the credibility of the resulting evidence. The strongest programs will combine careful animal-use justification with validated alternatives, high-quality husbandry, transparent governance, and reproducible science. Regional and country differences make local compliance essential, while collaboration on standards, data quality, and refinement can improve both research value and public trust.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Experimental Cynomolgus Monkey Market, by Research Type
7.1. Introduction
7.2. Drug Efficacy Testing
7.2.1. Biologics
7.2.2. Cell Therapies
7.2.3. Small Molecule Drugs
7.3. Pharmacology & Toxicology Studies
7.3.1. Acute Toxicity
7.3.2. Carcinogenicity Tests
7.3.3. Chronic Toxicity
7.4. Safety Assessment
7.4.1. Immunogenicity Studies
7.4.2. Preclinical Safety Evaluation
7.5. Vaccine Testing
8. Experimental Cynomolgus Monkey Market, by Health Status
8.1. Introduction
8.2. Disease Models
8.3. Genetic Variants
8.4. Healthy Cynomolgus Monkeys
9. Experimental Cynomolgus Monkey Market, by Gender
9.1. Introduction
9.2. Female
9.3. Male
10. Experimental Cynomolgus Monkey Market, by End-User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Contract Research Organizations
10.4. Pharmaceutical & Biotechnology Companies
11. Experimental Cynomolgus Monkey Market, by Disease Area
11.1. Introduction
11.2. Cardiovascular Studies
11.3. Genetic / Genomic Research
11.4. Immunology Research
11.5. Infectious Diseases
11.6. Neurological Research
11.7. Oncology Research
11.8. Respiratory Diseases
12. Experimental Cynomolgus Monkey Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Experimental Cynomolgus Monkey Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Experimental Cynomolgus Monkey Market, by Country
14.1. Introduction
14.2. United States
14.3. China
14.4. Germany
14.5. United Kingdom
14.6. India
14.7. Japan
14.8. Russia
14.9. Brazil
14.10. Canada
14.11. Italy
14.12. Mexico
14.13. France
14.14. Spain
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Alpha Genesis, Inc.
16.2. AMSBIO by Europa Biosite
16.3. Athens Research & Technology, Inc.
16.4. BioChain Institute Inc.
16.5. BioChemed Services
16.6. BioIVT LLC
16.7. Cell Biologics, Inc.
16.8. Creative Biolabs, Inc.
16.9. Hainan Jingang Biotech.,Co.LTD.
16.10. Hubei Topgene Biotechnology Co., Ltd.
16.11. Innovative Research Inc.
16.12. iQ Biosciences
16.13. Lab Bioreagents
16.14. ODIN Bioscience
16.15. Primate Product Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Experimental Cynomolgus Monkey Market, Years Considered for the Study
FIGURE 2. Global Experimental Cynomolgus Monkey Market, Research Design
FIGURE 3. Global Experimental Cynomolgus Monkey Market, Research Framework
FIGURE 4. Global Experimental Cynomolgus Monkey Market, Data Triangulation
FIGURE 5. Global Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Experimental Cynomolgus Monkey Market Size, by Research Type, 2025 vs 2032 (%)
FIGURE 7. Global Experimental Cynomolgus Monkey Market Size, by Research Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Experimental Cynomolgus Monkey Market Size, by Health Status, 2025 vs 2032 (%)
FIGURE 9. Global Experimental Cynomolgus Monkey Market Size, by Health Status, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Experimental Cynomolgus Monkey Market Size, by Gender, 2025 vs 2032 (%)
FIGURE 11. Global Experimental Cynomolgus Monkey Market Size, by Gender, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Experimental Cynomolgus Monkey Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 13. Global Experimental Cynomolgus Monkey Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Experimental Cynomolgus Monkey Market Size, by Disease Area, 2025 vs 2032 (%)
FIGURE 15. Global Experimental Cynomolgus Monkey Market Size, by Disease Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Experimental Cynomolgus Monkey Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Experimental Cynomolgus Monkey Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Experimental Cynomolgus Monkey Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Experimental Cynomolgus Monkey Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Experimental Cynomolgus Monkey Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Experimental Cynomolgus Monkey Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Experimental Cynomolgus Monkey Market Segmentation & Coverage
TABLE 2. Global Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
TABLE 3. Global Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 4. Global Drug Efficacy Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Drug Efficacy Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Drug Efficacy Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Biologics Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Biologics Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Biologics Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Cell Therapies Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Cell Therapies Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Cell Therapies Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Small Molecule Drugs Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Small Molecule Drugs Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Small Molecule Drugs Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Pharmacology & Toxicology Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Pharmacology & Toxicology Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Pharmacology & Toxicology Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Acute Toxicity Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Acute Toxicity Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Acute Toxicity Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Carcinogenicity Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Carcinogenicity Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Carcinogenicity Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Chronic Toxicity Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Chronic Toxicity Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Chronic Toxicity Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Safety Assessment Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Safety Assessment Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Safety Assessment Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Immunogenicity Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Immunogenicity Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Immunogenicity Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Preclinical Safety Evaluation Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Preclinical Safety Evaluation Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Preclinical Safety Evaluation Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Vaccine Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Vaccine Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Vaccine Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 41. Global Disease Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Disease Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Disease Models Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Genetic Variants Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Genetic Variants Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Genetic Variants Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Healthy Cynomolgus Monkeys Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Healthy Cynomolgus Monkeys Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Healthy Cynomolgus Monkeys Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 51. Global Female Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Female Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Female Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Male Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Male Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Male Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 58. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 68. Global Cardiovascular Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Cardiovascular Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Cardiovascular Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Genetic / Genomic Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Genetic / Genomic Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Genetic / Genomic Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Immunology Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Immunology Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Immunology Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Neurological Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Neurological Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Neurological Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Oncology Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Oncology Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Oncology Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Respiratory Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Respiratory Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Respiratory Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Experimental Cynomolgus Monkey Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Experimental Cynomolgus Monkey Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 95. Asia-Pacific Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 96. Asia-Pacific Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 97. Asia-Pacific Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 98. Asia-Pacific Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 99. North America Experimental Cynomolgus Monkey Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. North America Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 101. North America Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 102. North America Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 103. North America Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 104. North America Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 105. North America Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 106. North America Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 107. North America Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 108. Latin America Experimental Cynomolgus Monkey Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Latin America Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 110. Latin America Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 111. Latin America Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 112. Latin America Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 113. Latin America Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 114. Latin America Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 115. Latin America Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 116. Latin America Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 117. Europe Experimental Cynomolgus Monkey Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Europe Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 119. Europe Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 120. Europe Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 121. Europe Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 122. Europe Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 123. Europe Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 124. Europe Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 125. Europe Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 126. Middle East Experimental Cynomolgus Monkey Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Middle East Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 128. Middle East Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 129. Middle East Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 130. Middle East Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 131. Middle East Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 132. Middle East Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 133. Middle East Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 134. Middle East Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 135. Africa Experimental Cynomolgus Monkey Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Africa Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 137. Africa Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 138. Africa Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 139. Africa Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 140. Africa Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 141. Africa Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 142. Africa Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 143. Africa Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 144. Global Experimental Cynomolgus Monkey Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. ASEAN Experimental Cynomolgus Monkey Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. ASEAN Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 147. ASEAN Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 148. ASEAN Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 149. ASEAN Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 150. ASEAN Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 151. ASEAN Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 152. ASEAN Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 153. ASEAN Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 154. GCC Experimental Cynomolgus Monkey Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. GCC Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 156. GCC Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 157. GCC Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 158. GCC Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 159. GCC Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 160. GCC Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 161. GCC Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 162. GCC Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 163. European Union Experimental Cynomolgus Monkey Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. European Union Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 165. European Union Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 166. European Union Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 167. European Union Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 168. European Union Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 169. European Union Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 170. European Union Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 171. European Union Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 172. BRICS Experimental Cynomolgus Monkey Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. BRICS Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 174. BRICS Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 175. BRICS Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 176. BRICS Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 177. BRICS Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 178. BRICS Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 179. BRICS Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 180. BRICS Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 181. G7 Experimental Cynomolgus Monkey Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. G7 Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 183. G7 Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 184. G7 Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 185. G7 Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 186. G7 Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 187. G7 Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 188. G7 Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 189. G7 Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 190. NATO Experimental Cynomolgus Monkey Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. NATO Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 192. NATO Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 193. NATO Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 194. NATO Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 195. NATO Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 196. NATO Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 197. NATO Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 198. NATO Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 199. Global Experimental Cynomolgus Monkey Market Size, by Country, 2017-2032 (USD Million)
TABLE 200. United States Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
TABLE 201. United States Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 202. United States Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 203. United States Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 204. United States Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 205. United States Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 206. United States Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 207. United States Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 208. United States Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 209. China Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
TABLE 210. China Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 211. China Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 212. China Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 213. China Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 214. China Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 215. China Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 216. China Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 217. China Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 218. Germany Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
TABLE 219. Germany Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 220. Germany Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 221. Germany Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 222. Germany Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 223. Germany Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 224. Germany Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 225. Germany Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 226. Germany Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 227. United Kingdom Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
TABLE 228. United Kingdom Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 229. United Kingdom Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 230. United Kingdom Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 231. United Kingdom Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 232. United Kingdom Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 233. United Kingdom Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 234. United Kingdom Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 235. United Kingdom Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 236. India Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
TABLE 237. India Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 238. India Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 239. India Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 240. India Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 241. India Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 242. India Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 243. India Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 244. India Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 245. Japan Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
TABLE 246. Japan Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 247. Japan Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 248. Japan Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 249. Japan Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 250. Japan Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 251. Japan Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 252. Japan Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 253. Japan Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 254. Russia Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
TABLE 255. Russia Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 256. Russia Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 257. Russia Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 258. Russia Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 259. Russia Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 260. Russia Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 261. Russia Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 262. Russia Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 263. Brazil Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
TABLE 264. Brazil Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 265. Brazil Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 266. Brazil Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 267. Brazil Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 268. Brazil Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 269. Brazil Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 270. Brazil Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 271. Brazil Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 272. Canada Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
TABLE 273. Canada Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 274. Canada Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 275. Canada Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 276. Canada Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 277. Canada Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 278. Canada Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 279. Canada Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 280. Canada Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 281. Italy Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
TABLE 282. Italy Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 283. Italy Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 284. Italy Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 285. Italy Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 286. Italy Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 287. Italy Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 288. Italy Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 289. Italy Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 290. Mexico Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
TABLE 291. Mexico Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 292. Mexico Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 293. Mexico Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 294. Mexico Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 295. Mexico Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 296. Mexico Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 297. Mexico Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 298. Mexico Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 299. France Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
TABLE 300. France Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 301. France Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 302. France Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 303. France Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 304. France Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 305. France Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 306. France Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 307. France Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 308. Spain Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
TABLE 309. Spain Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 310. Spain Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 311. Spain Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 312. Spain Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 313. Spain Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 314. Spain Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 315. Spain Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 316. Spain Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 317. Australia Experimental Cynomolgus Monkey Market Size, 2017-2032 (USD Million)
TABLE 318. Australia Experimental Cynomolgus Monkey Market Size, by Research Type, 2017-2032 (USD Million)
TABLE 319. Australia Experimental Cynomolgus Monkey Market Size, by Drug Efficacy Testing, 2017-2032 (USD Million)
TABLE 320. Australia Experimental Cynomolgus Monkey Market Size, by Pharmacology & Toxicology Studies, 2017-2032 (USD Million)
TABLE 321. Australia Experimental Cynomolgus Monkey Market Size, by Safety Assessment, 2017-2032 (USD Million)
TABLE 322. Australia Experimental Cynomolgus Monkey Market Size, by Health Status, 2017-2032 (USD Million)
TABLE 323. Australia Experimental Cynomolgus Monkey Market Size, by Gender, 2017-2032 (USD Million)
TABLE 324. Australia Experimental Cynomolgus Monkey Market Size, by End-User, 2017-2032 (USD Million)
TABLE 325. Australia Experimental Cynomolgus Monkey Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 326. South Korea Experimental Cynomolg

Companies Mentioned

  • Alpha Genesis, Inc.
  • AMSBIO by Europa Biosite
  • Athens Research & Technology, Inc.
  • BioChain Institute Inc.
  • BioChemed Services
  • BioIVT LLC
  • Cell Biologics, Inc.
  • Creative Biolabs, Inc.
  • Hainan Jingang Biotech.,Co.LTD.
  • Hubei Topgene Biotechnology Co., Ltd.
  • Innovative Research Inc.
  • iQ Biosciences
  • Lab Bioreagents
  • ODIN Bioscience
  • Primate Product Inc.